Pay in 4 interest-free payments of $5.96 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
We're not just resellers
Oral GLP-1s for obesity saw a recent setback when in April (April 2025), Pfizer announced that it was discontinuing development of danuglipron, an oral GLP-1 receptor agonist, which was being investigated for chronic weight management, due to potential liver toxicity
Here's what those phrases actually mean, broken down one by one: "Clinician Prescribed": Source - LIV Body's official lander
Zhu, L., Zhou, J., Pan, Y., Lv, J., Liu, Y., Yu, S., & Zhang, Y
Report to FDA MedWatch (USA) or Yellow Card (UK)
US$ 29.18
US$ 25.73
US$ 22.21
